Two Different Ventilatory Strategies in Acute Respiratory Distress Syndrome Due to Community-acquired Pneumonia (STAMINA)
Community-acquired Pneumonia, Acute Respiratory Distress Syndrome
About this trial
This is an interventional treatment trial for Community-acquired Pneumonia focused on measuring mechanical ventilation, positive end-expiratory pressure, community-acquired pneumonia
Eligibility Criteria
Inclusion Criteria:
- Patients with community acquired pneumonia requiring invasive mechanical ventilation
- Bilateral pulmonary infiltrates on chest imaging not fully explained by fluid overload in the opinion of the attending physician
- One of the criteria below:
- Oxygen inspired fraction above 50% with a positive end-expiratory pressure of at least 8 cmH2O to main peripheral oxygen saturation above 93%, OR
- Arterial partial pressure of oxygen divided by inspired fraction of oxygen lower than 200 with PEEP values of at least 5 cmH2O
Exclusion Criteria:
- Patients with inclusion criteria for more than 36 hours
- Refusal of the patient´s legal representative
- Acute neurologic disease (stroke, brain trauma, or any disease that may cause intracranial hypertension)
- Patients with current airway fistula or barotrauma
- Patients on chronic home use of oxygen due to underlying lung disease
- Patients younger than 18 years
- Patients not on full code status
Sites / Locations
- Associação Evangélica Beneficente de Londrina - Hospital Evangélico de Londrina
- Hospital São José
- Hospital Nereu Ramos
- Centro Hospitalar Unimed
- Hospital do Coracao
- BP-A Beneficiência Portuguesa de São Paulo
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
ARDSNet strategy
STAMINA strategy
Patients will receive a mechanical ventilation strategy based on fixed values of positive end-expiratory pressure according to inspired fraction of oxygen. Plateau pressure will be limited at 30 cmH2O. This strategy will be mantained and monitored for 3 days, unless the patient dies or is extubated before. This arm is similar to the ARMA (Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Lung Injury and the Acute Respiratory Distress Syndrome) trial.
Patients will receive a mechanical ventilation strategy based on positive end-expiratory pressure tailored to achieve the optimal respiratory system compliance and to have driving pressure limited to 14 cmH2O. Plateau pressure will be limited at 30 cmH2O. This strategy will be mantained and monitored for 3 days, unless the patient dies or is extubated before.